Chinese General Practice ›› 2022, Vol. 25 ›› Issue (29): 3678-3685.DOI: 10.12114/j.issn.1007-9572.2022.0357
Special Issue: 泌尿系统疾病最新文章合集
• Article·Traditional Chinese Medicinal Research • Previous Articles Next Articles
Received:
2022-02-24
Revised:
2022-05-24
Published:
2022-10-15
Online:
2022-06-16
Contact:
Jingwei ZHOU
About author:
通讯作者:
周静威
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0357
组别 | 只数 | 体质量(g) | 肾重指数(%) |
---|---|---|---|
NC组 | 6 | 488.83±36.71 | 2.80±0.10 |
DKD亚组 | 6 | 230.33±38.61a | 11.11±0.93a |
QRXZF亚组 | 6 | 318.67±40.89ab | 9.13±1.04ab |
F值 | 68.92 | 127.93 | |
P值 | <0.01 | <0.01 |
Table 1 Comparison of body weight and kidney weight index in rats in control group,DKD and QRXZF subgroups
组别 | 只数 | 体质量(g) | 肾重指数(%) |
---|---|---|---|
NC组 | 6 | 488.83±36.71 | 2.80±0.10 |
DKD亚组 | 6 | 230.33±38.61a | 11.11±0.93a |
QRXZF亚组 | 6 | 318.67±40.89ab | 9.13±1.04ab |
F值 | 68.92 | 127.93 | |
P值 | <0.01 | <0.01 |
组别 | 只数 | 24 h尿微量白蛋白(mg/L) | Scr (μmol/L) | BUN (mmol/L) | ALB (g/L) |
---|---|---|---|---|---|
NC组 | 6 | 20.35±5.00 | 27.50±4.22 | 5.41 ± 0.28 | 27.9±1.95 |
DKD亚组 | 6 | 68.15±12.70a | 44.45±6.46a | 24.47±3.06a | 22.55±0.69a |
QRXZF亚组 | 6 | 41.19±7.0ab | 31.90±4.09b | 14.40±2.60ab | 25.68±1.16ab |
F值 | 26.55 | 10.22 | 54.98 | 23.09 | |
P值 | <0.01 | <0.01 | <0.01 | <0.01 |
Table 2 Comparison of the levels of Scr,BUN,ALB and 24 h Upro in rats in control group,DKD and QRXZF subgroups
组别 | 只数 | 24 h尿微量白蛋白(mg/L) | Scr (μmol/L) | BUN (mmol/L) | ALB (g/L) |
---|---|---|---|---|---|
NC组 | 6 | 20.35±5.00 | 27.50±4.22 | 5.41 ± 0.28 | 27.9±1.95 |
DKD亚组 | 6 | 68.15±12.70a | 44.45±6.46a | 24.47±3.06a | 22.55±0.69a |
QRXZF亚组 | 6 | 41.19±7.0ab | 31.90±4.09b | 14.40±2.60ab | 25.68±1.16ab |
F值 | 26.55 | 10.22 | 54.98 | 23.09 | |
P值 | <0.01 | <0.01 | <0.01 | <0.01 |
[1] |
|
[2] |
|
[3] |
|
[4] |
靳贺超,顾悦,张圆圆,等. 细胞焦亡与坏死性凋亡在糖尿病肾病中的作用及中医药干预研究进展[J]. 中国实验方剂学杂志,2022,28(3):58-67. DOI:10.13422/j.cnki.syfjx.20220336.
|
[5] |
尹琼丽,王一娜,李梅,等. 糖尿病肾病患者肾小管上皮细胞DcR2、p16表达变化及其与肾组织损伤程度和肾功能的相关性分析[J]. 临床和实验医学杂志,2017,16(17):1696-1700. DOI:10.3969/j.issn.1671-4695.2017.17.010.
|
[6] |
徐灵芝,任跃忠. 西格列汀抑制糖尿病肾病大鼠肾组织的细胞凋亡和炎症[J]. 细胞与分子免疫学杂志,2019,35(3):217-222. DOI:10.13423/j.cnki.cjcmi.008755.
|
[7] |
王莹,周静威,王珍,等. 糖尿病肾病中西医治疗进展[J]. 中国全科医学,2022,25(12):1411-1417. DOI:10.12114/j.issn.1007-9572.2021.02.117.
|
[8] |
付碧琼,陈佳,陈客宏,等. 肾康注射液抑制高糖诱导肾小管上皮细胞应激性衰老[J]. 中国中西医结合肾病杂志,2016,17(1):11-13,后插1.
|
[9] |
柯世业,石光耀,刘定辉,等. 人参皂苷Rb1通过Sirt3/SOD2通路延缓高糖诱导的人脐静脉内皮细胞衰老[J]. 中山大学学报:医学版,2019,40(3):329-336. DOI:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2019.0047.
|
[10] |
曹东维,韩文贝,何劲松,等. 茶多酚调节STAT3/miR-126/端粒信号通路活性延缓高糖诱导的人肾小球系膜细胞衰老[J]. 中国中药杂志,2018,43(23):4678-4684. DOI:10.19540/j.cnki.cjcmm.20181031.003.
|
[11] |
陈彦旭,金智生,何流,等. 红芪多糖对高糖培养下雪旺细胞Bcl-2/Caspase-3信号通路的影响[J]. 中国实验方剂学杂志,2022,28(6):71-78. DOI:10.13422/j.cnki.syfjx.20220694.
|
[12] |
秦德哲,何晨,李巴仑,等. 白藜芦醇通过缓解内质网应激治疗小鼠糖尿病[J]. 中国细胞生物学学报,2020,42(9):1570-1577.
|
[13] |
张亮. 基于中医象思维探讨肾衰饮干预慢性肾功能衰竭大鼠的机制研究[D]. 沈阳:辽宁中医药大学,2021.
|
[14] |
高亚斌,王耀献,郭敬,等. "以热为本,以期为纲"论治中期糖尿病肾病[J]. 中华中医药杂志,2019,34(12):5723-5725.
|
[15] |
王晓娜,王耀献,闫润泽,等. 清热消癥法治疗中期糖尿病肾病临床疗效观察[J]. 中华中医药杂志,2020,35(11):5873-5876.
|
[16] |
|
[17] | |
[18] |
|
[19] |
|
[20] |
张颖,张晓良,赵宇. 细胞衰老在糖尿病肾病进展中的作用[J]. 肾脏病与透析肾移植杂志,2021,30(6):565-570.
|
[21] |
|
[22] |
|
[23] |
|
[24] |
陈永昕,刘婉卿,周青,等. 褪黑素延缓糖尿病大鼠肾脏细胞衰老的机制研究[J]. 安徽医科大学学报,2021,56(7):1032-1036,1041. DOI:10.19405/j.cnki.issn1000-1492.2021.07.006.
|
[25] |
姜雪. 二甲双胍通过MBNL1/miR-130a-3p/STAT3途径延缓糖尿病肾病肾小管上皮细胞衰老[D]. 沈阳:中国医科大学,2020.
|
[26] |
侯君,成玥,李佳识,等. 黄芪黄酮对糖尿病周围神经病变大鼠背根神经节的保护作用及机制[J]. 广西医学,2021,43(22):2704-2710. DOI:10.11675/j.issn.0253-4304.2021.22.14.
|
[27] |
|
[28] |
|
[29] | |
[30] |
|
[31] |
|
[1] | MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102. |
[2] | WANG Zhen, SHEN Guoqi, LI Yanan, ZHU Yinghua, QIU Hang, ZHENG Di, XU Tongda, LI Wenhua. Development and Validation of a Risk Prediction Model for Contrast-induced Acute Kidney Injury after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(29): 3650-3656. |
[3] | WANG Xiaowen, XIAO Tongling, WANG Yi, YANG Ying, XIA Xiaoshuang, LI Xin. Relationship between Homocysteine Level and Acute Kidney Injury in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(26): 3290-3296. |
[4] | NIU Guohui, LI Tingting, ZHU Dengna, WANG Jun, LIU Hongxing, WANG Xin, ZHANG Mengmeng, XIE Jiayang. Clinical Characteristics of Global Developmental Delay in Children of Different Genders [J]. Chinese General Practice, 2023, 26(26): 3276-3281. |
[5] | YANG Xuhong, WANG Minglei, LIU Wenxiao, MA Wanlong, ZHAO Jianguo, HUANG Xueying, WANG Minxing, DING Xiangchun, WANG Xiaodong. Evaluation of Cognitive Impairment in Patients with Minimal Hepatic Encephalopathy Based on Degree Centrality of Resting-state Blood Oxygenation Level-dependent Functional Magnetic Resonance Imaging [J]. Chinese General Practice, 2023, 26(24): 3033-3041. |
[6] | ZHAO Wei, TANG Rongjie, YANG Shanshan, YANG Fang, SUN Feng, LIAN Qiufang. The Role and Molecules Mechanism of Klotho in Renal Injury in Salt-sensitive Hypertension [J]. Chinese General Practice, 2023, 26(24): 3042-3049. |
[7] | ZI Jing, DU Xueping. Exploratory Research on Models of Operating Elderly Care Facilities by Community Health Institutions from Integrated Medical and Elderly Care Perspective: a Case Study of Yinling Elderly Nursing Home Held by Beijing Xicheng District Yuetan Community Health Center [J]. Chinese General Practice, 2023, 26(19): 2434-2438. |
[8] | ZHAO Lizhen, LI Weimin, JIANG Ruixia. Clinical Value of Systemic Immune-inflammation Index in the Diagnosis of Diabetic Kidney Disease in Community-dwelling Elderly Patients with Type 2 Diabetes [J]. Chinese General Practice, 2023, 26(18): 2227-2231. |
[9] | SHU Tao, GUO Zheng, WANG Fei, CHEN Shuyan. Analysis of the Correlation between Time in Range and Diabetic Kidney Disease [J]. Chinese General Practice, 2023, 26(15): 1873-1879. |
[10] | WANG Fangfang, CUI Yanru, LI Jiayu, PANG Rizhao, ZHANG Anren. Possible Mechanism of Improving Neurodegenerative Diseases via Rejuvenation of Mitochondrial Function by Intermittent Fasting [J]. Chinese General Practice, 2023, 26(12): 1530-1536. |
[11] | YAN Peng, SONG Jianling, FANG Xiangdong. Recent Developments in Parathyroid Hormone Type 1 Receptor and Kidney Disease [J]. Chinese General Practice, 2023, 26(11): 1398-1403. |
[12] | XU Wei, XU Jiyuan, LI Maoqin, LU Fei, CHENG Shuli. Predictive Value of Color Doppler Ultrasound for Acute Kidney Injury in Patients with Septic Shock [J]. Chinese General Practice, 2023, 26(09): 1104-1111. |
[13] | SHEN Fei, JIANG Weiping, MEI Xiaobin, HAN Yiping, ZHAO Jiayi, FAN Jian, GU Juan, SHEN Yanhong, XU Hongmei, ZHANG Dan, MEN Ying, DING Haiguang, CHEN Caiping, HAN Junhua. Influence of Microbiota-modulating Agents on Gut Flora in Community Patients with Diabetic Nephropathy [J]. Chinese General Practice, 2023, 26(09): 1112-1117. |
[14] | ZHANG Sen, BAI Hongying, LI Qianqian, LI Caixia. Total Deep Medullary Veins Score in Cerebral Small Vessel Disease: Association with Imaging Markers and Factors Related to Its Elevation [J]. Chinese General Practice, 2023, 26(06): 681-686. |
[15] | LAN Hailong, NING Guanyuan, HUANG Xiangmin, XIAO Yeyu. Sequences of SS_TSE and Modified Abdominal T2WI Magnetic Resonance Imaging in the Diagnosis of Neonatal Pneumonia [J]. Chinese General Practice, 2023, 26(03): 308-312. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||